Brazil health regulator Anvisa allows Chinese COVID-19 vaccine trial

Saturday, 4 July 2020 16:32

Clinical trials of a potential coronavirus vaccine developed by China's Sinovac has got the go-ahead in Brazil.

Trials will be conducted by 12 research centres in Sao Paulo, Rio de Janeiro, Minas Gerais, Brasilia, Rio Grande do Sul and Parana.

According to Brazilian health regulator Anvisa, the agreement with Sinovac will also look at the transference of technology to produce the potential vaccine locally.

It comes as the country surpassed 1.5 million confirmed cases of COVID-19, with the death toll at 63,174.

More from International News

Israel says it's moving towards Lebanon ceasefire

Israel is moving towards a ceasefire in the war with Hezbollah but there are still issues to address, its government said on Monday, while two senior Lebanese officials voiced guarded optimism of a deal soon even as Israeli strikes pounded Lebanon.
15 Turkish-backed fighters killed by Kurdish forces in Syria

At least 15 Ankara-backed Syrian fighters were killed on Sunday after Kurdish-led forces infiltrated their territory in the country’s north, the Syrian Observatory for Human Rights war monitor said.
March demanding release of Pakistan's Imran Khan nears capital

A march by hundreds of supporters to demand the release of jailed former Prime Minister Imran Khan reached the fringes of Pakistan's capital of Islamabad on Monday, his party and officials said, amid reports of violence elsewhere.
16 rescued after tourist boat sinks off Egypt's Red Sea coast

Egyptian authorities rescued 16 people after a tourist boat sank off its Red Sea coast, as search operations continued for the remaining passengers and crew members.